Zachary Roberts Allogene Therapeutics, Inc. (ALLO) insider trading activity

Zachary Roberts is EVP of R&D of Allogene Therapeutics, Inc.. Currently has a direct ownership of 643,135 shares of ALLO, which is worth approximately $778,193. The most recent transaction as insider was on Feb 03, 2025, when has been sold 18,832 shares (Common Stock) at a price of $1.7 per share, resulting in proceeds of $32,014. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 643K

0% 3M change

24.82% 12M change

Total Value Held $778,193

Zachary Roberts Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 03 2025	SELL Open market or private sale	$32,014 $1.7 p/Share	18,832 Reduced 2.84%	643,135 Common Stock
Jan 24 2025	BUY Grant, award, or other acquisition	-	173,913 Added 20.81%	661,967 Common Stock
Jan 21 2025	SELL Open market or private sale	$48,414 $1.78 p/Share	27,199 Reduced 5.28%	488,054 Common Stock
Jan 25 2024	BUY Grant, award, or other acquisition	-	140,000 Added 21.37%	515,253 Common Stock
Jan 22 2024	SELL Payment of exercise price or tax liability	$78,267 $3.17 p/Share	24,690 Reduced 6.17%	375,253 Common Stock
Mar 22 2023	BUY Grant, award, or other acquisition	-	148,035 Added 27.01%	399,943 Common Stock
Jan 20 2023	BUY Grant, award, or other acquisition	-	251,908 Added 50.0%	251,908 Common Stock

Also insider at

TIL

Instil Bio, Inc. Healthcare

Chief Medical Officer

Zachary Roberts

EVP of R&D

Dallas, TX

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALLO shares.

Notify only if

Value

Insider Trading

Get notified when an Allogene Therapeutics, Inc. insider buys or sells ALLO shares.

Notify only if

Operation

Value

Type

News

Receive news related to Allogene Therapeutics, Inc.

Track Activities on ALLO

Account